{
    "clinical_study": {
        "@rank": "114401", 
        "arm_group": [
            {
                "arm_group_label": "10 days of Trimethoprim-Sulfamethoxazole", 
                "arm_group_type": "Active Comparator", 
                "description": "Trimethoprim-Sulfamethoxazole dosed at 5 mg Trimethoprim/kg/dose twice a day, to a maximum of 320 mg Trimethoprim/dose twice a day"
            }, 
            {
                "arm_group_label": "3 days of Trimethoprim-Sulfamethoxazole", 
                "arm_group_type": "Experimental", 
                "description": "Trimethoprim-Sulfamethoxazole dosed at 5 mg Trimethoprim/kg/dose twice a day, to a maximum of 320 mg Trimethoprim/dose twice a day"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to determine if there is a difference in treatment failures\n      between 3 and 10 days of antibiotics for uncomplicated skin abscesses after they have been\n      surgically drained."
        }, 
        "brief_title": "Efficacy Study of 3 Versus 10 Days of Antibiotics in Skin Abscesses After Surgical Drainage", 
        "completion_date": {
            "#text": "July 2012", 
            "@type": "Actual"
        }, 
        "condition": [
            "Skin Disease, Bacterial", 
            "Abscess"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Abscess", 
                "Skin Diseases", 
                "Skin Diseases, Bacterial"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients presenting with a skin abscess that requires surgical drainage (induration\n             greater than 2 cm in diameter)\n\n          -  minimally invasive surgical technique with the insertion of a subcutaneous drain can\n             be utilized on the patient\n\n        Exclusion Criteria:\n\n          -  patients requiring immediate hospitalization\n\n          -  patients who have received 2 or more doses of antibiotics in the previous 36 hours\n\n          -  patients with diabetes, sickle-cell disease, an immuno-compromising disease, an\n             underlying medical condition predisposing the patient to frequent hospitalizations or\n             medical visits, or indwelling catheters or percutaneous medical devices\n\n          -  patients with a concurrent, different, additional infection\n\n          -  patients with an allergy to Trimethoprim-sulfamethoxazole"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "17 Years", 
            "minimum_age": "3 Months"
        }, 
        "enrollment": {
            "#text": "281", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "December 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02024867", 
            "org_study_id": "DB 2456"
        }, 
        "intervention": {
            "arm_group_label": [
                "10 days of Trimethoprim-Sulfamethoxazole", 
                "3 days of Trimethoprim-Sulfamethoxazole"
            ], 
            "intervention_name": "Trimethoprim-Sulfamethoxazole", 
            "intervention_type": "Drug", 
            "other_name": [
                "Septra", 
                "Bactrim"
            ]
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Sulfamethoxazole", 
                "Trimethoprim", 
                "Trimethoprim-Sulfamethoxazole Combination"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Methicillin resistent Staphylococcus aureus", 
            "Staphylococcus aureus"
        ], 
        "lastchanged_date": "December 27, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Buffalo", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "14222"
                }, 
                "name": "Women & Children's Hospital of Buffalo"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Trial of 3 Versus 10 Days of Trimethoprim-Sulfamethoxazole in Community-Associated Skin Abscesses After Surgical Drainage", 
        "other_outcome": {
            "measure": "Number of participants with side effects from antibiotics in 3 versus 10 day treatment groups", 
            "safety_issue": "Yes", 
            "time_frame": "up to 2 weeks after surgical drainage"
        }, 
        "overall_official": [
            {
                "affiliation": "University at Buffalo", 
                "last_name": "Lucy C Holmes, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "University at Buffalo", 
                "last_name": "Howard Faden, MD", 
                "role": "Study Chair"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number of treatment failures in 3 versus 10 day antibiotic groups", 
            "safety_issue": "No", 
            "time_frame": "up to 2 weeks after surgical drainage"
        }, 
        "reference": [
            {
                "PMID": "19409657", 
                "citation": "Duong M, Markwell S, Peter J, Barenkamp S. Randomized, controlled trial of antibiotics in the management of community-acquired skin abscesses in the pediatric patient. Ann Emerg Med. 2010 May;55(5):401-7. Epub 2009 May 5."
            }, 
            {
                "PMID": "20346539", 
                "citation": "Schmitz GR, Bruner D, Pitotti R, Olderog C, Livengood T, Williams J, Huebner K, Lightfoot J, Ritz B, Bates C, Schmitz M, Mete M, Deye G. Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection. Ann Emerg Med. 2010 Sep;56(3):283-7. doi: 10.1016/j.annemergmed.2010.03.002. Epub 2010 Mar 26. Erratum in: Ann Emerg Med. 2010 Nov;56(5):588."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02024867"
        }, 
        "responsible_party": {
            "investigator_affiliation": "State University of New York at Buffalo", 
            "investigator_full_name": "Lucy Holmes, MD", 
            "investigator_title": "Clinical Associate Professor of Pediatrics", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Incidence of new lesions in index patient in 3 versus 10 day antibiotic groups", 
                "safety_issue": "No", 
                "time_frame": "monthly, up to 6 months after surgical drainage"
            }, 
            {
                "measure": "Incidence of new lesions in household contacts in 3 versus 10 day antibiotic groups", 
                "safety_issue": "No", 
                "time_frame": "monthly, up to 6 months after surgical drainage"
            }
        ], 
        "source": "State University of New York at Buffalo", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "New York State Department of Health", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Women & Children's Hospital of Buffalo", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Lucy Holmes, MD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}